Exact Mass: 673.4553

Exact Mass Matches: 673.4553

Found 339 metabolites which its exact mass value is equals to given mass value 673.4553, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

PC(14:1(9Z)/14:1(9Z))

(2-{[(2R)-2,3-bis[(9Z)-tetradec-9-enoyloxy]propyl phosphonato]oxy}ethyl)trimethylazanium

C36H68NO8P (673.4682)


PC(14:1(9Z)/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/14:1(9Z)), in particular, consists of two chains of myristoleic acid at the C-1 and C-2 positions. The myristoleic acid moieties are derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

   

PE(14:0/P-18:1(11Z))

(2-aminoethoxy)[(2R)-2-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(14:0/P-18:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/P-18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n7 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(14:0/P-18:1(9Z))

(2-aminoethoxy)[(2R)-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(14:0/P-18:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:0/P-18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:1n9 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(14:1(9Z)/P-18:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-octadec-1-en-1-yloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(14:1(9Z)/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(14:1(9Z)/P-18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

   

PE(16:1(9Z)/P-16:0)

(2-aminoethoxy)[(2R)-2-[(1Z)-hexadec-1-en-1-yloxy]-3-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(16:1(9Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(16:1(9Z)/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(16:1(9Z)/P-16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-16:0/16:1(9Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(9Z)-hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(P-16:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-16:0/16:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/16:1(9Z)), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitoleic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:0/14:1(9Z))

(2-aminoethoxy)[(2R)-3-[(1Z)-octadec-1-en-1-yloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(P-18:0/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:0/14:1(9Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/14:1(9Z)), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristoleic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(11Z)/14:0)

(2-aminoethoxy)[(2R)-3-[(1Z,11Z)-octadeca-1,11-dien-1-yloxy]-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(P-18:1(11Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(11Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(11Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n7 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n7 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(P-18:1(9Z)/14:0)

(2-aminoethoxy)[(2R)-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-2-(tetradecanoyloxy)propoxy]phosphinic acid

C37H72NO7P (673.5046)


PE(P-18:1(9Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-18:1(9Z)/14:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:1(9Z)/14:0), in particular, consists of one chain of plasmalogen 18:1n9 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:1n9 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:1(9Z)/16:1(9Z))

{2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy}[2-(methylamino)ethoxy]phosphinic acid

C36H68NO8P (673.4682)


PE-NMe(14:1(9Z)/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/16:1(9Z)), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one 9Z-hexadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(16:1(9Z)/14:1(9Z))

{3-[(9Z)-hexadec-9-enoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy}[2-(methylamino)ethoxy]phosphinic acid

C36H68NO8P (673.4682)


PE-NMe(16:1(9Z)/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/14:1(9Z)), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

9,10-Didehydroacidissiminin epoxide

9,10-Didehydroacidissiminin epoxide

C43H63NO5 (673.4706)


   
   

Arg Ile Arg Val Met

Arg Ile Arg Val Met

C28H55N11O6S (673.4057)


   

(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[hexadec-9-enoyloxy]propoxy]phosphinic acid

(2-aminoethoxy)[3-[hexadec-1-en-1-yloxy]-2-[hexadec-9-enoyloxy]propoxy]phosphinic acid

C37H72NO7P (673.5046)


   

RIRVM

Arg-Ile-Arg-Val-Met

C28H55N11O6S (673.4057)


   

PC(14:1/14:1)

3,5,9-Trioxa-4-phosphatricos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-tetradecenyl)oxy]-, inner salt, 4-oxide, [R-(E,E)]-

C36H68NO8P (673.4682)


   

PC(14:1/14:1)[U]

3,5,9-Trioxa-4-phosphatricos-18-en-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxo-9-tetradecenyl)oxy]-, inner salt, 4-oxide, (Z,Z)-

C36H68NO8P (673.4682)


   

Lecithin

1,2-Dimyristoleoyl-rac-glycero-3-phosphocholine

C36H68NO8P (673.4682)


   

PE(32:1)

1-(1-Enyl-palmitoyl)-2-palmitoleoyl-sn-glycero-3-phosphoethanolamine

C37H72NO7P (673.5046)


   

PE(13:0/18:2(9Z,12Z))

1-tridecanoyl-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(14:0/17:2(9Z,12Z))

1-tetradecanoyl-2-(9Z,12Z-heptadecadienoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(14:1(9Z)/17:1(9Z))

1-(9Z-tetradecenoyl)-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(15:1(9Z)/16:1(9Z))

1-(9Z-pentadecenoyl)-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(16:1(9Z)/15:1(9Z))

1-(9Z-hexadecenoyl)-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(17:1(9Z)/14:1(9Z))

1-(9Z-heptadecenoyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(17:2(9Z,12Z)/14:0)

1-(9Z,12Z-heptadecadienoyl)-2-tetradecanoyl-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE(18:2(9Z,12Z)/13:0)

1-(9Z,12Z-octadecadienoyl)-2-tridecanoyl-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PC 28:2

1-decanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine

C36H68NO8P (673.4682)


   

PE 31:2

1-(9Z,12Z-heptadecadienoyl)-2-tetradecanoyl-glycero-3-phosphoethanolamine

C36H68NO8P (673.4682)


   

PE O-32:2

1-(1Z-octadecenyl)-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C37H72NO7P (673.5046)


   

Bis[2-(di-1-adamantylphosphino)ethyl]amine

Bis[2-(di-1-adamantylphosphino)ethyl]amine

C44H69NP2 (673.4905)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] (Z)-hexadec-9-enoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] tetradecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] tetradecanoate

C37H72NO7P (673.5046)


   

2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate

2,3-bis[[(Z)-tetradec-9-enoyl]oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   
   

HexCer 9:1;2O/24:6

HexCer 9:1;2O/24:6

C39H63NO8 (673.4553)


   

HexCer 13:2;2O/20:5

HexCer 13:2;2O/20:5

C39H63NO8 (673.4553)


   

HexCer 17:3;2O/16:4

HexCer 17:3;2O/16:4

C39H63NO8 (673.4553)


   

HexCer 15:2;2O/18:5

HexCer 15:2;2O/18:5

C39H63NO8 (673.4553)


   

HexCer 11:1;2O/22:6

HexCer 11:1;2O/22:6

C39H63NO8 (673.4553)


   

HexCer 15:3;2O/18:4

HexCer 15:3;2O/18:4

C39H63NO8 (673.4553)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (21Z,24Z)-dotriaconta-21,24-dienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (21Z,24Z)-dotriaconta-21,24-dienoate

C37H72NO7P (673.5046)


   

Lnape 7:0/N-24:2

Lnape 7:0/N-24:2

C36H68NO8P (673.4682)


   

Lnape 22:2/N-9:0

Lnape 22:2/N-9:0

C36H68NO8P (673.4682)


   

Lnape 9:0/N-22:2

Lnape 9:0/N-22:2

C36H68NO8P (673.4682)


   

Lnape 26:2/N-5:0

Lnape 26:2/N-5:0

C36H68NO8P (673.4682)


   

Lnape 5:0/N-26:2

Lnape 5:0/N-26:2

C36H68NO8P (673.4682)


   

Lnape 24:2/N-7:0

Lnape 24:2/N-7:0

C36H68NO8P (673.4682)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-octoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

Lnape 16:2/N-15:0

Lnape 16:2/N-15:0

C36H68NO8P (673.4682)


   

Lnape 15:0/N-16:2

Lnape 15:0/N-16:2

C36H68NO8P (673.4682)


   

Lnape 18:2/N-13:0

Lnape 18:2/N-13:0

C36H68NO8P (673.4682)


   

Lnape 18:1/N-13:1

Lnape 18:1/N-13:1

C36H68NO8P (673.4682)


   

Lnape 14:1/N-17:1

Lnape 14:1/N-17:1

C36H68NO8P (673.4682)


   

Lnape 20:2/N-11:0

Lnape 20:2/N-11:0

C36H68NO8P (673.4682)


   

Lnape 11:0/N-20:2

Lnape 11:0/N-20:2

C36H68NO8P (673.4682)


   

Lnape 10:0/N-21:2

Lnape 10:0/N-21:2

C36H68NO8P (673.4682)


   

Lnape 17:2/N-14:0

Lnape 17:2/N-14:0

C36H68NO8P (673.4682)


   

Lnape 16:1/N-15:1

Lnape 16:1/N-15:1

C36H68NO8P (673.4682)


   

Lnape 14:0/N-17:2

Lnape 14:0/N-17:2

C36H68NO8P (673.4682)


   

Lnape 13:0/N-18:2

Lnape 13:0/N-18:2

C36H68NO8P (673.4682)


   

Lnape 21:2/N-10:0

Lnape 21:2/N-10:0

C36H68NO8P (673.4682)


   

Lnape 19:2/N-12:0

Lnape 19:2/N-12:0

C36H68NO8P (673.4682)


   

Lnape 12:0/N-19:2

Lnape 12:0/N-19:2

C36H68NO8P (673.4682)


   

Lnape 17:1/N-14:1

Lnape 17:1/N-14:1

C36H68NO8P (673.4682)


   

Lnape 13:1/N-18:1

Lnape 13:1/N-18:1

C36H68NO8P (673.4682)


   

Lnape 15:1/N-16:1

Lnape 15:1/N-16:1

C36H68NO8P (673.4682)


   

HexCer 8:0;3O/22:2;(2OH)

HexCer 8:0;3O/22:2;(2OH)

C36H67NO10 (673.4765)


   

HexCer 12:1;3O/18:1;(2OH)

HexCer 12:1;3O/18:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 10:0;3O/20:2;(2OH)

HexCer 10:0;3O/20:2;(2OH)

C36H67NO10 (673.4765)


   

HexCer 12:0;3O/18:2;(2OH)

HexCer 12:0;3O/18:2;(2OH)

C36H67NO10 (673.4765)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] hexanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(15Z,18Z)-hexacosa-15,18-dienoxy]propan-2-yl] hexanoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] octanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] octanoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] butanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] butanoate

C37H72NO7P (673.5046)


   

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-icosa-11,14-dienoxy]-2-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(13Z,16Z)-docosa-13,16-dienoxy]-2-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-nonoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[2-pentanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-pentanoyloxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(15Z,18Z)-hexacosa-15,18-dienoxy]-2-propanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (Z)-nonadec-9-enoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C37H72NO7P (673.5046)


   

2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytetradecane-1-sulfonic acid

2-[[(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-5,8,11,14,17,20,23-heptaenoyl]amino]-3-hydroxytetradecane-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] tridecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propan-2-yl] tridecanoate

C37H72NO7P (673.5046)


   

(4E,8E,12E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] pentadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propan-2-yl] pentadecanoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C37H72NO7P (673.5046)


   

(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

(E)-2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

C40H67NO5S (673.474)


   

(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetradec-4-ene-1-sulfonic acid

(E)-2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxytetradec-4-ene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] (Z)-tridec-9-enoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C37H72NO7P (673.5046)


   

(4E,8E,12E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] (Z)-pentadec-9-enoate

C37H72NO7P (673.5046)


   

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexadec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]hexadec-4-ene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E,12E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C37H72NO7P (673.5046)


   

(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytetradeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxytetradeca-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] undecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-henicosa-11,14-dienoxy]propan-2-yl] undecanoate

C37H72NO7P (673.5046)


   

(4E,8E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]icosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]icosa-4,8-diene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetradeca-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxytetradeca-4,8-diene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E,12E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexadeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]hexadeca-4,8-diene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] decanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(13Z,16Z)-docosa-13,16-dienoxy]propan-2-yl] decanoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] dodecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] dodecanoate

C37H72NO7P (673.5046)


   

(4E,8E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]docosa-4,8-diene-1-sulfonic acid

C40H67NO5S (673.474)


   

(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C40H67NO5S (673.474)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] (Z)-heptadec-9-enoate

C37H72NO7P (673.5046)


   

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[2-decanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-decanoyloxy-3-[(9Z,12Z)-nonadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-[(Z)-pentadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-pentadec-9-enoxy]-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

2-amino-3-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-tridecoxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

2-amino-3-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-undecoxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-undecoxypropoxy]phosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

[3-decoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decoxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

2-amino-3-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]-2-undecanoyloxypropoxy]phosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

2-amino-3-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-tridecanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

[2-dodecanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-dodecanoyloxy-3-[(9Z,12Z)-heptadeca-9,12-dienoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-dodecoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecoxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-hexadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

2-amino-3-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

2-amino-3-[[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

C35H64NO9P (673.4318)


   

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-octanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-octanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-dodecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-dodecanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-decanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-decanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

HexCer 17:1;3O/13:1;(2OH)

HexCer 17:1;3O/13:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 15:1;3O/15:1;(2OH)

HexCer 15:1;3O/15:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 16:2;3O/14:0;(2OH)

HexCer 16:2;3O/14:0;(2OH)

C36H67NO10 (673.4765)


   

HexCer 18:2;3O/12:0;(2OH)

HexCer 18:2;3O/12:0;(2OH)

C36H67NO10 (673.4765)


   

HexCer 17:2;3O/13:0;(2OH)

HexCer 17:2;3O/13:0;(2OH)

C36H67NO10 (673.4765)


   

HexCer 18:1;3O/12:1;(2OH)

HexCer 18:1;3O/12:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 16:1;3O/14:1;(2OH)

HexCer 16:1;3O/14:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 14:2;3O/16:0;(2OH)

HexCer 14:2;3O/16:0;(2OH)

C36H67NO10 (673.4765)


   

HexCer 15:2;3O/15:0;(2OH)

HexCer 15:2;3O/15:0;(2OH)

C36H67NO10 (673.4765)


   

HexCer 14:1;3O/16:1;(2OH)

HexCer 14:1;3O/16:1;(2OH)

C36H67NO10 (673.4765)


   

HexCer 14:0;3O/16:2;(2OH)

HexCer 14:0;3O/16:2;(2OH)

C36H67NO10 (673.4765)


   

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-hexadeca-9,12-dienoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (Z)-octadec-9-enoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C37H72NO7P (673.5046)


   

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(Z)-hexadec-9-enoxy]-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (Z)-tetradec-9-enoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] hexadecanoate

C37H72NO7P (673.5046)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(9Z,12Z)-octadeca-9,12-dienoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C37H72NO7P (673.5046)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropan-2-yl] (Z)-heptadec-9-enoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (Z)-hexadec-9-enoate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-octadec-9-enoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (Z)-octadec-9-enoate

C36H68NO8P (673.4682)


   

[3-butanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-butanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C36H68NO8P (673.4682)


   

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-heptanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C36H68NO8P (673.4682)


   

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(11Z,14Z)-icosa-11,14-dienoyl]oxy-3-octanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C36H68NO8P (673.4682)


   

[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecanoyloxy-2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[3-decanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-decanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[3-acetyloxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-acetyloxy-2-[(15Z,18Z)-hexacosa-15,18-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-nonanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(Z)-pentadec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

4-[2-decanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-decanoyloxy-3-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-dodec-5-enoyl]oxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (6E,9E)-octadeca-6,9-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (6E,9E)-octadeca-6,9-dienoate

C36H68NO8P (673.4682)


   

[(2R)-3-decanoyloxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-hexadec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-hexadec-7-enoate

C36H68NO8P (673.4682)


   

4-[2-dodecanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-dodecanoyloxy-3-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9E,11E)-octadeca-9,11-dienoate

C36H68NO8P (673.4682)


   

4-[3-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-dec-4-enoyl]oxy-3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (9E,12E)-octadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

4-[3-dodecanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-dodecanoyloxy-2-[(7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2S)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (2E,4E)-octadeca-2,4-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (2E,4E)-octadeca-2,4-dienoate

C36H68NO8P (673.4682)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (5E,8E)-icosa-5,8-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (5E,8E)-icosa-5,8-dienoate

C36H68NO8P (673.4682)


   

[(2R)-3-decanoyloxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2S)-2-decanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-7-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-7-enoate

C37H72NO7P (673.5046)


   

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(E)-dodec-5-enoyl]oxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (5E,8E)-icosa-5,8-dienoate

C36H68NO8P (673.4682)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (11E,14E)-icosa-11,14-dienoate

C36H68NO8P (673.4682)


   

[3-dodecanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-dodecanoyloxy-2-[(4E,7E)-hexadeca-4,7-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C36H68NO8P (673.4682)


   

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (11E,14E)-icosa-11,14-dienoate

C36H68NO8P (673.4682)


   

[(2S)-2-decanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(9E,11E)-octadeca-9,11-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2R)-3-decanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(9E,12E)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (9E,11E)-octadeca-9,11-dienoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (9E,11E)-octadeca-9,11-dienoate

C36H68NO8P (673.4682)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (9E,12E)-heptadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(6E,9E)-dodeca-6,9-dienoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] (E)-hexadec-9-enoate

C37H72NO7P (673.5046)


   

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-decanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-decanoyloxy-2-[(5E,8E,11E,14E,17E)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-heptadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] (E)-heptadec-9-enoate

C36H68NO8P (673.4682)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] (9E,12E)-heptadeca-9,12-dienoate

C36H68NO8P (673.4682)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-tetradec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] (E)-tetradec-9-enoate

C37H72NO7P (673.5046)


   

[(2S)-2-decanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2S)-2-decanoyloxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-[(2E,4E)-octadeca-2,4-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2R)-3-decanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-decanoyloxy-2-[(6E,9E)-octadeca-6,9-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

4-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-hexadec-9-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-hexadec-9-enoate

C36H68NO8P (673.4682)


   

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[3-[(E)-dec-4-enoyl]oxy-2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-hexadec-9-enoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (E)-hexadec-9-enoate

C36H68NO8P (673.4682)


   

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C40H67NO7 (673.4917)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (6E,9E)-octadeca-6,9-dienoate

C36H68NO8P (673.4682)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (2E,4E)-octadeca-2,4-dienoate

C36H68NO8P (673.4682)


   

[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C36H68NO8P (673.4682)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-heptadec-9-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] (E)-heptadec-9-enoate

C36H68NO8P (673.4682)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-hexadec-7-enoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (E)-hexadec-7-enoate

C36H68NO8P (673.4682)


   

2-[[(8E,12E)-3,4-dihydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E)-3,4-dihydroxy-2-[[(Z)-tridec-9-enoyl]amino]octadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H70N2O7P+ (673.492)


   

2-[[(8E,12E,16E)-3,4-dihydroxy-2-(tridecanoylamino)octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(8E,12E,16E)-3,4-dihydroxy-2-(tridecanoylamino)octadeca-8,12,16-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C36H70N2O7P+ (673.492)


   

1,2-Dimyristoleoyl-sn-glycero-3-phosphocholine

1,2-Dimyristoleoyl-sn-glycero-3-phosphocholine

C36H68NO8P (673.4682)


   

MePC(28:2)

MePC(10:0(1)_18:2)

C37H72NO7P (673.5046)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

DGCC 28:7;O

DGCC 28:7;O

C38H59NO9 (673.419)


   
   

DGTS 28:7;O2

DGTS 28:7;O2

C38H59NO9 (673.419)


   
   
   
   
   

PC O-16:0/12:3;O

PC O-16:0/12:3;O

C36H68NO8P (673.4682)


   
   

PC O-18:0/9:4;O2

PC O-18:0/9:4;O2

C35H64NO9P (673.4318)


   
   

PC O-20:0/8:3;O

PC O-20:0/8:3;O

C36H68NO8P (673.4682)


   
   
   
   
   

PC P-14:0/15:1 or PC O-14:1/15:1

PC P-14:0/15:1 or PC O-14:1/15:1

C37H72NO7P (673.5046)


   
   

PC P-16:1/13:0 or PC O-16:2/13:0

PC P-16:1/13:0 or PC O-16:2/13:0

C37H72NO7P (673.5046)


   
   

PC P-18:1/11:0 or PC O-18:2/11:0

PC P-18:1/11:0 or PC O-18:2/11:0

C37H72NO7P (673.5046)


   

PC P-18:1/9:2;O2

PC P-18:1/9:2;O2

C35H64NO9P (673.4318)


   

PC P-20:0/7:3;O2

PC P-20:0/7:3;O2

C35H64NO9P (673.4318)


   

PC P-20:1/7:2;O2

PC P-20:1/7:2;O2

C35H64NO9P (673.4318)


   

PC P-20:1/8:1;O

PC P-20:1/8:1;O

C36H68NO8P (673.4682)


   
   

PC P-29:1 or PC O-29:2

PC P-29:1 or PC O-29:2

C37H72NO7P (673.5046)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

PE O-18:0/13:3;O

PE O-18:0/13:3;O

C36H68NO8P (673.4682)


   
   
   
   
   
   
   
   

PE P-14:0/18:1 or PE O-14:1/18:1

PE P-14:0/18:1 or PE O-14:1/18:1

C37H72NO7P (673.5046)


   
   

PE P-16:0/16:1 or PE O-16:1/16:1

PE P-16:0/16:1 or PE O-16:1/16:1

C37H72NO7P (673.5046)


   
   

PE P-16:1/16:0 or PE O-16:2/16:0

PE P-16:1/16:0 or PE O-16:2/16:0

C37H72NO7P (673.5046)


   
   

PE P-17:1/15:0 or PE O-17:2/15:0

PE P-17:1/15:0 or PE O-17:2/15:0

C37H72NO7P (673.5046)


   

PE P-18:0/12:3;O2

PE P-18:0/12:3;O2

C35H64NO9P (673.4318)


   
   

PE P-18:0/14:1 or PE O-18:1/14:1

PE P-18:0/14:1 or PE O-18:1/14:1

C37H72NO7P (673.5046)


   

PE P-18:1/12:2;O2

PE P-18:1/12:2;O2

C35H64NO9P (673.4318)


   
   

PE P-18:1/14:0 or PE O-18:2/14:0

PE P-18:1/14:0 or PE O-18:2/14:0

C37H72NO7P (673.5046)


   

PE P-20:0/11:2;O

PE P-20:0/11:2;O

C36H68NO8P (673.4682)


   
   

PE P-20:1/12:0 or PE O-20:2/12:0

PE P-20:1/12:0 or PE O-20:2/12:0

C37H72NO7P (673.5046)


   
   

PE P-22:1/10:0 or PE O-22:2/10:0

PE P-22:1/10:0 or PE O-22:2/10:0

C37H72NO7P (673.5046)


   
   

PE P-32:1 or PE O-32:2

PE P-32:1 or PE O-32:2

C37H72NO7P (673.5046)


   
   
   
   
   
   
   
   
   
   

CerP 14:2;O2/23:0;O

CerP 14:2;O2/23:0;O

C37H72NO7P (673.5046)


   

CerP 15:1;O2/22:1;O

CerP 15:1;O2/22:1;O

C37H72NO7P (673.5046)


   

CerP 15:2;O2/22:0;O

CerP 15:2;O2/22:0;O

C37H72NO7P (673.5046)


   

CerP 16:2;O2/21:0;O

CerP 16:2;O2/21:0;O

C37H72NO7P (673.5046)


   

CerP 17:1;O2/20:1;O

CerP 17:1;O2/20:1;O

C37H72NO7P (673.5046)


   

CerP 17:2;O2/20:0;O

CerP 17:2;O2/20:0;O

C37H72NO7P (673.5046)


   

CerP 17:2;O2/22:6

CerP 17:2;O2/22:6

C39H64NO6P (673.4471)


   

CerP 18:2;O2/19:0;O

CerP 18:2;O2/19:0;O

C37H72NO7P (673.5046)


   

CerP 19:1;O2/18:1;O

CerP 19:1;O2/18:1;O

C37H72NO7P (673.5046)


   

CerP 19:2;O2/18:0;O

CerP 19:2;O2/18:0;O

C37H72NO7P (673.5046)


   

CerP 20:2;O2/17:0;O

CerP 20:2;O2/17:0;O

C37H72NO7P (673.5046)


   

CerP 21:2;O2/16:0;O

CerP 21:2;O2/16:0;O

C37H72NO7P (673.5046)


   

CerP 22:2;O2/15:0;O

CerP 22:2;O2/15:0;O

C37H72NO7P (673.5046)


   
   
   
   

4-{5,9,12-trihydroxy-6,13-dimethyl-10-methylidene-2-oxo-14-[(5e,7e)-3,7,11-trimethyl-4-oxoheptadeca-5,7-dien-1-yl]-1-oxa-4,8,11-triazacyclotetradeca-4,8,11-trien-3-yl}butanoic acid

4-{5,9,12-trihydroxy-6,13-dimethyl-10-methylidene-2-oxo-14-[(5e,7e)-3,7,11-trimethyl-4-oxoheptadeca-5,7-dien-1-yl]-1-oxa-4,8,11-triazacyclotetradeca-4,8,11-trien-3-yl}butanoic acid

C37H59N3O8 (673.4302)


   

4-[5,9,12-trihydroxy-6,13-dimethyl-10-methylidene-2-oxo-14-(3,7,11-trimethyl-4-oxoheptadeca-5,7-dien-1-yl)-1-oxa-4,8,11-triazacyclotetradeca-4,8,11-trien-3-yl]butanoic acid

4-[5,9,12-trihydroxy-6,13-dimethyl-10-methylidene-2-oxo-14-(3,7,11-trimethyl-4-oxoheptadeca-5,7-dien-1-yl)-1-oxa-4,8,11-triazacyclotetradeca-4,8,11-trien-3-yl]butanoic acid

C37H59N3O8 (673.4302)